MedPath

Fluorescein

Generic Name
Fluorescein
Brand Names
Ak-fluor, Altafluor, Diofluor, Fluorescite, Fluress
Drug Type
Small Molecule
Chemical Formula
C20H12O5
CAS Number
2321-07-5
Unique Ingredient Identifier
TPY09G7XIR

Overview

A phthalic indicator dye that appears yellow-green in normal tear film and bright green in a more alkaline medium, such as the aqueous humor, and is used therapeutically as a diagnostic aid in corneal injuries and corneal trauma. It has been approved by FDA for use in externally applied drugs and cosmetics. (From Merck Index, 12th ed; American Medical Association Drug Evaluations; 1995, p2275)

Background

A phthalic indicator dye that appears yellow-green in normal tear film and bright green in a more alkaline medium, such as the aqueous humor, and is used therapeutically as a diagnostic aid in corneal injuries and corneal trauma. It has been approved by FDA for use in externally applied drugs and cosmetics. (From Merck Index, 12th ed; American Medical Association Drug Evaluations; 1995, p2275)

Indication

For diagnostic imaging. Primarily indicated in diagnostic fluorescein angiography or angioscopy of the fundus and of the iris vasculature.

Associated Conditions

  • Peritoneal dialysis therapy
  • Pneumocystis Jirovecii Pneumonia

FDA Approved Products

Fluorescein Sodium and Benoxinate Hydrochloride
Manufacturer:Oceanside Pharmaceuticals
Route:OPHTHALMIC
Strength:2.6 mg in 1 mL
Approved: 2020/03/19
NDC:68682-732
FUL-GLO
Manufacturer:Akorn
Route:OPHTHALMIC
Strength:0.6 mg in 1 1
Approved: 2012/03/22
NDC:17478-403
AK-FLUOR
Manufacturer:Akorn
Route:INTRAVENOUS
Strength:100 mg in 1 mL
Approved: 2016/08/15
NDC:17478-253
AK-FLUOR
Manufacturer:Akorn
Route:INTRAVENOUS
Strength:250 mg in 1 mL
Approved: 2016/08/15
NDC:17478-250
GloStrips
Manufacturer:Nomax Inc.
Route:OPHTHALMIC
Strength:0.6 mg in 1 1
Approved: 2019/12/23
NDC:51801-003

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath